Hansoh Pharmaceutical Group

3692 · HKEX · HKD

$34.14−3.29%−$1.16

Close · October 2, 2026

At a glance

Revenue growth: +22.57%; 2025 vs 2024
Net income growth: +27.07%; 2025 vs 2024
Net margin: 37.0%; 2024: 35.7%

Financial data

Amounts in millions of CNY; per-share values in CNY; shares in millions.

Income statement · Quarterly
Item	Q2 2026	Q4 2025	Q2 2025	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021
Total revenue	8,304	7,595	7,434	5,755	6,506	5,593	4,511	4,948	4,434	5,534
Cost of revenue	674	842	677	531	586	501	531	471	399	454
Gross profit	7,630	6,753	6,756	5,225	5,920	5,091	3,980	4,477	4,035	5,080
Selling, general and administrative	2,187	2,575	2,161	2,434	2,075	2,241	2,000	2,172	1,975	2,409
Research and development	1,739	1,917	1,441	1,505	1,196	1,168	929	954	739	1,110
Operating income	3,685	2,248	3,154	1,305	2,597	1,644	1,035	1,378	1,230	1,440
EBIT	3,685	2,248	3,154	1,305	2,597	1,644	1,035	1,378	1,230	1,440
EBITDA	3,867	2,427	3,337	1,476	2,802	1,815	1,210	1,554	1,378	1,579
Interest expense	48.6	1.5	1.6	1.7	4.9	35.9	30.7	29.5	28.7	25.7
Pre-tax income	5,009	2,862	3,688	1,967	3,118	2,266	1,500	1,439	1,509	1,753
Income tax	751	442	553	321	393	278	211	154	211	331
Net income	4,258	2,421	3,135	1,646	2,726	1,989	1,289	1,286	1,298	1,422
Net income to common shareholders	4,258	2,421	3,135	1,646	2,726	1,989	1,289	1,286	1,298	1,422
Basic EPS	0.70	0.40	0.53	0.28	0.46	0.34	0.22	0.22	0.22	0.24
Diluted EPS	0.70	0.40	0.53	0.28	0.46	0.30	0.22	0.22	0.22	0.24
Average shares (basic)	6,057	5,988	5,938	5,934	5,926	5,926	5,924	5,915	5,917	5,922
Average shares (diluted)	6,138	6,005	5,956	5,953	5,947	6,096	5,944	5,939	5,919	6,003
Dividend per share	0.25	0.18	0.21	0.13	0.19	0.13	0.07	0.05	0.04	—